Q3 EPS Estimates for Huron Consulting Group Cut by Wedbush

Key Points

• Wedbush analyst D. Ives lowered Huron Consulting Group's Q3 2025 earnings per share estimate from $1.86 to $1.72, amid a broader pessimistic outlook regarding the company's earnings.
• Barrington Research increased their price target for Huron's shares from $167.00 to $173.00, maintaining an "outperform" rating, while Wall Street Zen downgraded the stock from a "buy" to a "hold" rating.
• Huron Consulting Group reported a quarterly earnings of $1.89 per share, exceeding the consensus estimate, even as revenue slightly missed expectations at $402.50 million.

Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) - Analysts at Wedbush cut their Q3 2025 earnings per share estimates for shares of Huron Consulting Group in a note issued to investors on Friday, August 1st. Wedbush analyst D. Ives now forecasts that the business services provider will post earnings of $1.72 per share for the quarter, down from their previous estimate of $1.86. The consensus estimate for Huron Consulting Group's current full-year earnings is $6.10 per share. Wedbush also issued estimates for Huron Consulting Group's FY2025 earnings at $7.54 EPS, Q1 2026 earnings at $2.01 EPS and FY2026 earnings at $8.60 EPS.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The business services provider reported $1.89 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.79 by $0.10. Huron Consulting Group had a return on equity of 25.52% and a net margin of 6.60%. The company had revenue of $402.50 million during the quarter, compared to analyst estimates of $402.67 million. During the same quarter in the previous year, the firm posted $1.68 EPS. The firm's quarterly revenue was up 8.3% on a year-over-year basis.

HURN has been the topic of a number of other research reports. Wall Street Zen downgraded Huron Consulting Group from a "buy" rating to a "hold" rating in a research report on Friday, May 2nd. Barrington Research increased their price objective on Huron Consulting Group from $173.00 to $176.00 and gave the stock an "outperform" rating in a research note on Thursday. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $171.50.

Huron Consulting Group Price Performance

NASDAQ HURN traded up $1.57 on Monday, reaching $130.48. The company's stock had a trading volume of 97,380 shares, compared to its average volume of 204,923. The firm has a market cap of $2.26 billion, a PE ratio of 22.77 and a beta of 0.26. Huron Consulting Group has a 52 week low of $101.84 and a 52 week high of $155.00. The business has a 50-day moving average price of $135.28 and a 200 day moving average price of $138.34. The company has a current ratio of 1.99, a quick ratio of 1.99 and a debt-to-equity ratio of 1.35.

Insider Activity

In other news, Director Joy Brown sold 668 shares of the stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $149.74, for a total transaction of $100,026.32. Following the completion of the transaction, the director directly owned 8,896 shares in the company, valued at $1,332,087.04. This represents a 6.98% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director H Eugene Lockhart sold 1,040 shares of the business's stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $136.74, for a total transaction of $142,209.60. Following the sale, the director directly owned 8,162 shares in the company, valued at $1,116,071.88. The trade was a 11.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 2,708 shares of company stock valued at $375,161. 2.15% of the stock is currently owned by company insiders.

Institutional Trading of Huron Consulting Group

Several large investors have recently added to or reduced their stakes in the stock. Summit Investment Advisors Inc. lifted its position in shares of Huron Consulting Group by 5.5% in the fourth quarter. Summit Investment Advisors Inc. now owns 1,838 shares of the business services provider's stock valued at $228,000 after acquiring an additional 96 shares in the last quarter. Savant Capital LLC raised its stake in Huron Consulting Group by 6.9% during the 2nd quarter. Savant Capital LLC now owns 1,686 shares of the business services provider's stock valued at $232,000 after acquiring an additional 109 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of Huron Consulting Group by 3.1% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 4,039 shares of the business services provider's stock worth $502,000 after purchasing an additional 121 shares during the period. Tower Research Capital LLC TRC boosted its position in Huron Consulting Group by 27.3% during the fourth quarter. Tower Research Capital LLC TRC now owns 569 shares of the business services provider's stock worth $71,000 after acquiring an additional 122 shares during the last quarter. Finally, CWM LLC increased its holdings in shares of Huron Consulting Group by 55.9% during the 1st quarter. CWM LLC now owns 407 shares of the business services provider's stock worth $58,000 after buying an additional 146 shares during the last quarter. Institutional investors own 93.90% of the company's stock.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.